Individual genomes instead of race for personalized medicine.

@article{Ng2008IndividualGI,
  title={Individual genomes instead of race for personalized medicine.},
  author={Pauline Crystal Ng and Qian Zhao and Stephen Levy and Robert Strausberg and J. Craig Venter},
  journal={Clinical pharmacology and therapeutics},
  year={2008},
  volume={84 3},
  pages={
          306-9
        }
}
The cost of sequencing and genotyping is aggressively decreasing, enabling pervasive personalized genomic screening for drug reactions. Drug-metabolizing genes have been characterized sufficiently to enable practitioners to go beyond simplistic ethnic characterization and into the precisely targeted world of personal genomics. We examine six drug-metabolizing genes in J. Craig Venter and James Watson, two Caucasian men whose genomes were recently sequenced. Their genetic differences underscore… CONTINUE READING
BETA

Figures and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Editorial: The Complexity of Reporting Race and Ethnicity in Orthopaedic Research

  • Clinical orthopaedics and related research
  • 2018
VIEW 2 EXCERPTS
CITES BACKGROUND

Genetic factors affecting drug disposition in Asian cancer patients.

  • Expert opinion on drug metabolism & toxicology
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

The fallacy of racial pharmacogenomics.

  • Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
  • 2011
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 17 REFERENCES

2000 to 2006

E. Cox, D. Mager, Weisbart, E. Geographic Variation Trends in Prescription Use
  • 23
  • 2008

The complete genome of an individual by massively parallel DNA sequencing

Wheeler, D.A
  • Nature 452,
  • 2008

The pharmacogenetics and pharmacogenomics knowledge base : accentuating the knowledge

T. Hernandez-Boussard
  • Nucleic Acids Res .
  • 2008

Genetic polymorphisms of cytochrome P 450 2 D 6 ( CYP 2 D 6 ) : clinical consequences , evolutionary aspects and functional diversity

M. Ingelman-Sundberg
  • Pharmacogenomics J .
  • 2007

Similar Papers

Loading similar papers…